167 related articles for article (PubMed ID: 10684168)
21. Adenovirus-mediated transfer of type IV collagen alpha5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane.
Heikkilä P; Tibell A; Morita T; Chen Y; Wu G; Sado Y; Ninomiya Y; Pettersson E; Tryggvason K
Gene Ther; 2001 Jun; 8(11):882-90. PubMed ID: 11423936
[TBL] [Abstract][Full Text] [Related]
22. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
23. Renal transplantation in patients with Alport syndrome.
Kashtan CE
Pediatr Transplant; 2006 Sep; 10(6):651-7. PubMed ID: 16911486
[TBL] [Abstract][Full Text] [Related]
24. [Case of anti-glomerular basement membrane antibody nephritis in a patient who was able to withdraw from dialysis and gave birth twice but underwent living renal transplantation due to progression to end-stage renal failure 15 years after onset].
Iwamoto I; Naiki Y; Nose K; Akiyama T; Sakaguchi M; Matsuoka T; Samejima K; Hiroaki S; Funauchi M
Nihon Jinzo Gakkai Shi; 2009; 51(8):1080-5. PubMed ID: 19999588
[TBL] [Abstract][Full Text] [Related]
25. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.
Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145
[TBL] [Abstract][Full Text] [Related]
26. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome.
Hajime N; Michiko A; Atsunori K; Tatsuo K; Yuko N; Naoki O; Katsuhiko S
Ther Apher Dial; 2009 Aug; 13(4):373-7. PubMed ID: 19695077
[TBL] [Abstract][Full Text] [Related]
27. Goodpasture's syndrome in a patient using cocaine--a case report and review of the literature.
Sirvent AE; Enríquez R; Andrada E; Amorós F; Gallego JA; González C; Padilla I
Clin Nephrol; 2007 Sep; 68(3):182-5. PubMed ID: 17915623
[TBL] [Abstract][Full Text] [Related]
28. A case of living-related renal transplant from the donor with membranous nephropathy.
Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakai K; Sakamoto S; Urasaki K; Yanagisawa A; Fukatsu A; Yoshimura N
Clin Transplant; 2009 Aug; 23 Suppl 20():62-6. PubMed ID: 19594600
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
[TBL] [Abstract][Full Text] [Related]
30. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
Wilson JC; Yoon HS; Walker RJ; Eccles MR
Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
[TBL] [Abstract][Full Text] [Related]
31. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
[TBL] [Abstract][Full Text] [Related]
32. Recurrence of Goodpasture syndrome without circulating anti-glomerular basement membrane antibodies after kidney transplant, a case report.
Thibaud V; Rioux-Leclercq N; Vigneau C; Morice S
BMC Nephrol; 2019 Jan; 20(1):6. PubMed ID: 30621605
[TBL] [Abstract][Full Text] [Related]
33. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity.
Cui Z; Zhao MH
Clin Immunol; 2005 Jul; 116(1):77-82. PubMed ID: 15925834
[TBL] [Abstract][Full Text] [Related]
34. [Goodpasture's syndrome].
Shinjo SK; Hasegawa EM; Costa Malheiros DM; Levy-Neto M
Acta Reumatol Port; 2008; 33(2):220-3. PubMed ID: 18604188
[TBL] [Abstract][Full Text] [Related]
35. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.4. Chronic graft dysfunction. De novo renal disease after transplantation.
EBPG Expert Group on Renal Transplantation
Nephrol Dial Transplant; 2002; 17 Suppl 4():15-6. PubMed ID: 12091620
[TBL] [Abstract][Full Text] [Related]
36. [Anti-GBM disease].
Yamada A
Nihon Rinsho; 2005 May; 63 Suppl 5():530-4. PubMed ID: 15954405
[No Abstract] [Full Text] [Related]
37. Quantitative analysis of type IV collagen subchains in the glomerular basement membrane of patients with Alport syndrome with confocal microscopy.
Su J; Liu ZH; Zeng CH; Wei-Gong ; Chen HP; Li LS
Nephrol Dial Transplant; 2006 Jul; 21(7):1838-47. PubMed ID: 16574687
[TBL] [Abstract][Full Text] [Related]
38. A 59-kD renal antigen as a new target for rapidly progressive glomerulonephritis.
Audard V; Hellmark T; El Karoui K; Noël LH; Pardon A; Desvaux D; Touchard G; Remy P; Lang P; Sahali D
Am J Kidney Dis; 2007 May; 49(5):710-6. PubMed ID: 17472855
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary: renal syndrome with a focus on anti-GBM disease.
Sanders JS; Rutgers A; Stegeman CA; Kallenberg CG
Semin Respir Crit Care Med; 2011 Jun; 32(3):328-34. PubMed ID: 21674418
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.
Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT
Stem Cells; 2006 Nov; 24(11):2448-55. PubMed ID: 16873763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
